Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

1.

Difference of morphology and immunophenotype between central and peripheral squamous cell carcinomas of the lung.

Hayashi T, Sano H, Egashira R, Tabata K, Tanaka T, Nakayama T, Kashima Y, Hori T, Nunomura S, Fukuoka J.

Biomed Res Int. 2013;2013:157838. doi: 10.1155/2013/157838. Epub 2013 Aug 29.

PMID:
24069587
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Value of P63 and CK5/6 in distinguishing squamous cell carcinoma from adenocarcinoma in lung fine-needle aspiration specimens.

Khayyata S, Yun S, Pasha T, Jian B, McGrath C, Yu G, Gupta P, Baloch Z.

Diagn Cytopathol. 2009 Mar;37(3):178-83. doi: 10.1002/dc.20975.

PMID:
19170169
[PubMed - indexed for MEDLINE]
3.

Optimal combination of immunohistochemical markers for subclassification of non-small cell lung carcinomas: A tissue microarray study of poorly differentiated areas.

Noh S, Shim H.

Lung Cancer. 2012 Apr;76(1):51-5. doi: 10.1016/j.lungcan.2011.09.008. Epub 2011 Oct 5.

PMID:
21978426
[PubMed - indexed for MEDLINE]
4.

Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.

Rekhtman N, Paik PK, Arcila ME, Tafe LJ, Oxnard GR, Moreira AL, Travis WD, Zakowski MF, Kris MG, Ladanyi M.

Clin Cancer Res. 2012 Feb 15;18(4):1167-76. doi: 10.1158/1078-0432.CCR-11-2109. Epub 2012 Jan 6.

PMID:
22228640
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens.

Rekhtman N, Ang DC, Sima CS, Travis WD, Moreira AL.

Mod Pathol. 2011 Oct;24(10):1348-59. doi: 10.1038/modpathol.2011.92. Epub 2011 May 27.

PMID:
21623384
[PubMed - indexed for MEDLINE]
Free Article
6.

A 6-antibody panel for the classification of lung adenocarcinoma versus squamous cell carcinoma.

Tacha D, Yu C, Bremer R, Qi W, Haas T.

Appl Immunohistochem Mol Morphol. 2012 May;20(3):201-7. doi: 10.1097/PAI.0b013e31823d7f0e.

PMID:
22498669
[PubMed - indexed for MEDLINE]
7.

Rapid multiplex immunohistochemistry using the 4-antibody cocktail YANA-4 in differentiating primary adenocarcinoma from squamous cell carcinoma of the lung.

Yanagita E, Imagawa N, Ohbayashi C, Itoh T.

Appl Immunohistochem Mol Morphol. 2011 Dec;19(6):509-13. doi: 10.1097/PAI.0b013e318212f027.

PMID:
21415705
[PubMed - indexed for MEDLINE]
8.

Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study.

Brunnström H, Johansson L, Jirström K, Jönsson M, Jönsson P, Planck M.

Am J Clin Pathol. 2013 Jul;140(1):37-46. doi: 10.1309/AJCP50RDXSCSBTBO.

PMID:
23765532
[PubMed - indexed for MEDLINE]
Free Article
9.

TTF-1 and p63 for distinguishing pulmonary small-cell carcinoma from poorly differentiated squamous cell carcinoma in previously pap-stained cytologic material.

Kalhor N, Zander DS, Liu J.

Mod Pathol. 2006 Aug;19(8):1117-23. Epub 2006 May 5.

PMID:
16680154
[PubMed - indexed for MEDLINE]
Free Article
10.

Characterization of the immunophenotype of the tumor budding and its prognostic implications in squamous cell carcinoma of the lung.

Taira T, Ishii G, Nagai K, Yoh K, Takahashi Y, Matsumura Y, Kojima M, Ohmatsu H, Goto K, Niho S, Takashima H, Inoue H, Ohe Y, Ochiai A.

Lung Cancer. 2012 Jun;76(3):423-30. doi: 10.1016/j.lungcan.2011.11.010. Epub 2011 Dec 6.

PMID:
22153829
[PubMed - indexed for MEDLINE]
11.

[Comparison by dynamic enhancement in spiral CT to differentiate peripheral squamous cell carcinoma from adenocarcinoma of the lung].

Li XS, Zhang WS, Xiong MH, Xiao XS.

Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):70-3. Chinese.

PMID:
16737627
[PubMed - indexed for MEDLINE]
12.

Histopathologic classification of lung cancer: Relevance of cytokeratin and TTF-1 immunophenotyping.

Johansson L.

Ann Diagn Pathol. 2004 Oct;8(5):259-67.

PMID:
15494931
[PubMed - indexed for MEDLINE]
13.

Dual color multiplex TTF-1 + Napsin A and p63 + CK5 immunostaining for subcategorizing of poorly differentiated pulmonary non-small carcinomas into adenocarcinoma and squamous cell carcinoma in fine needle aspiration specimens.

Sethi S, Geng L, Shidham VB, Archuletta P, Bandyophadhyay S, Feng J, Madan S, Shi D, Tranchida P, Giorgadze T.

Cytojournal. 2012;9:10. doi: 10.4103/1742-6413.94570. Epub 2012 Mar 31.

PMID:
22582081
[PubMed]
Free PMC Article
14.

Combined double CK5/P63 stain: useful adjunct test for diagnosing pulmonary squamous cell carcinoma.

Fatima N, Cohen C, Lawson D, Siddiqui MT.

Diagn Cytopathol. 2012 Nov;40(11):943-8. doi: 10.1002/dc.21678. Epub 2011 Apr 6.

PMID:
21472873
[PubMed - indexed for MEDLINE]
15.

Evaluation of napsin A, cytokeratin 5/6, p63, and thyroid transcription factor 1 in adenocarcinoma versus squamous cell carcinoma of the lung.

Whithaus K, Fukuoka J, Prihoda TJ, Jagirdar J.

Arch Pathol Lab Med. 2012 Feb;136(2):155-62. doi: 10.5858/arpa.2011-0232-OA.

PMID:
22288962
[PubMed - indexed for MEDLINE]
16.

Clinicopathologic characteristics of peripheral squamous cell carcinoma of the lung.

Funai K, Yokose T, Ishii G, Araki K, Yoshida J, Nishimura M, Nagai K, Nishiwaki Y, Ochiai A.

Am J Surg Pathol. 2003 Jul;27(7):978-84.

PMID:
12826890
[PubMed - indexed for MEDLINE]
17.

Histologic prognostic factors for small-sized squamous cell carcinomas of the peripheral lung.

Maeshima AM, Maeshima A, Asamura H, Matsuno Y.

Lung Cancer. 2006 Apr;52(1):53-8. Epub 2006 Feb 14.

PMID:
16483689
[PubMed - indexed for MEDLINE]
18.

Primary esophageal small cell carcinoma with concomitant invasive squamous cell carcinoma or carcinoma in situ.

Yamamoto J, Ohshima K, Ikeda S, Iwashita A, Kikuchi M.

Hum Pathol. 2003 Nov;34(11):1108-15.

PMID:
14652811
[PubMed - indexed for MEDLINE]
19.

Use of thyroid transcription factor 1, PE-10, and cytokeratins 7 and 20 in discriminating between primary lung carcinomas and metastatic lesions in fine-needle aspiration biopsy specimens.

Chhieng DC, Cangiarella JF, Zakowski MF, Goswami S, Cohen JM, Yee HT.

Cancer. 2001 Oct 25;93(5):330-6.

PMID:
11668468
[PubMed - indexed for MEDLINE]
20.

Subclassification of non-small cell lung carcinomas lacking morphologic differentiation on biopsy specimens: Utility of an immunohistochemical panel containing TTF-1, napsin A, p63, and CK5/6.

Mukhopadhyay S, Katzenstein AL.

Am J Surg Pathol. 2011 Jan;35(1):15-25. doi: 10.1097/PAS.0b013e3182036d05.

PMID:
21164283
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk